Why the study?
Does the angiotensin-converting enzyme deletion variant genotype influence long-term renal allograft survival in Caucasian kidney transplant recipients?
Does the angiotensin-converting enzyme deletion variant genotype influence long-term renal allograft survival in Caucasian kidney transplant recipients?
The angiotensin-converting enzyme insertion/deletion polymorphism in either the donor or recipient does not significantly influence long-term renal allograft survival in Caucasian patients.
No takes yet. Share an insight, caveat, or question.
ACE genotyping not warranted for donor-recipient matching; leaves open whether other variants influence Caucasian allograft survival.
Beige et al. (1997) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: